Homology mediated end joining enables efficient non-viral targeted integration of large DNA templates in primary human T cells
Webber, B. R.; Johnson, M. J.; Slipek, N. S.; Lahr, W. S.; DeFeo, A. P.; Skeate, J. G.; Qiu, X.; Rathmann, B.; Diers, M. D.; Wick, B.; Henley, T.; Choudhry, M.; McIvor, R. S.; Moriarity, B. S.
Show abstract
Adoptive cellular therapy using genetically engineered immune cells holds tremendous promise for the treatment of advanced cancers. While the number of available receptors targeting tumor specific antigens continues to grow, the current reliance on viral vectors for clinical production of engineered immune cells remains a significant bottleneck limiting translation of promising new therapies. Here, we describe an optimized methodology for efficient CRISPR-Cas9 based, non-viral engineering of primary human T cells that overcomes key limitations of previous approaches. By synergizing temporal optimization of reagent delivery, reagent composition, and integration mechanism, we achieve targeted integration of large DNA cargo at efficiencies nearing those of viral vector platforms with minimal toxicity. CAR-T cells generated using our approach are highly functional and elicit potent anti-tumor cytotoxicity in vitro and in vivo. Importantly, our method is readily adaptable to cGMP compliant manufacturing and clinical scale-up, offering a near-term alternative to the use of viral vectors for production of genetically engineered T cells for cancer immunotherapy.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Epigenetic control of multiple genes with a single lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays 96%
- CRISPRCas9-mediated gene disruption of endogenous co-receptors confers broad resistance to HIV-1 in human primary cells and humanized mice 95%
- High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells 95%
Similar papers in this journal
- An aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout for allogeneic CAR-T cells generation 97%
- A functional screening platform for engineering chimeric antigen receptors with reduced on-target, off-tumour activation 96%
- A Precision Gene Engineered B Cell Medicine Producing Sustained Levels of Active Factor IX for Hemophilia B Therapy 95%
Similar papers in this journal
- Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting 96%
- Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice 95%
- Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy 95%
Similar papers in this journal
- Collagen-binding IL-12 expressing STEAP1 CAR-T cells reduce toxicity and eradicate mouse prostate cancer in combination with checkpoint inhibitors 95%
- Acoustogenetic Control of CAR T Cells via Focused Ultrasound 94%
- Bioengineering multifunctional extracellular vesicles for targeted delivery of biologics to T cells 93%
Similar papers in this journal
- Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells 95%
- Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction 95%
- Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.